Matiakin G G, Ivanov V M, Ivanova O V, Sheĭkin M M
Stomatologiia (Mosk). 2013;92(6):12-5.
The efficiency of remaxol for prevention and treatment of chemoradiotherapy toxicity effects in patients with advanced oral cancer was evaluated. Ninety-five oral cancer patients were using remaxol both locally (mouth rinse solution) and by intravenous infusion, 87 patients were included in control group. Intravenous remaxol proved to be effective for mucositis and nephrotoxicity prevention by chemoradiotherapy.
评估了瑞马索（remaxol）对晚期口腔癌患者放化疗毒性作用的预防和治疗效果。95例口腔癌患者局部使用（漱口液）和静脉输注瑞马索，87例患者纳入对照组。静脉输注瑞马索被证明对放化疗引起的粘膜炎和肾毒性有预防作用。
